SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-368434
Filing Date
2017-12-14
Accepted
2017-12-13 17:41:33
Documents
4
Period of Report
2017-12-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d508596d8k.htm 8-K 19534
2 EX-10.1 d508596dex101.htm EX-10.1 272184
3 EX-99.1 d508596dex991.htm EX-99.1 9342
4 GRAPHIC g508596g07k48.gif GRAPHIC 11761
  Complete submission text file 0001193125-17-368434.txt   318535
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36281 | Film No.: 171254722
SIC: 2834 Pharmaceutical Preparations